scholarly article | Q13442814 |
P50 | author | Kristian Thorlund | Q30089886 |
Nick Bansback | Q37838997 | ||
Edward J. Mills | Q89591828 | ||
P2093 | author name string | Steven Kelly | |
Isabella Ghement | |||
Milo A Puhan | |||
James Wright | |||
P2860 | cites work | Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis | Q21093272 |
Grading quality of evidence and strength of recommendations | Q24562409 | ||
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial | Q24605205 | ||
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact | Q24652537 | ||
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
Meta-analysis in clinical trials | Q27860779 | ||
Indirect comparisons of competing interventions | Q28183606 | ||
How should meta-regression analyses be undertaken and interpreted? | Q28193388 | ||
Estimating the power of indirect comparisons: a simulation study | Q28743349 | ||
Combination of direct and indirect evidence in mixed treatment comparisons | Q29619499 | ||
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials | Q29619501 | ||
Interpreting trial results in light of conflicting evidence: a Bayesian analysis of adjuvant chemotherapy for non-small-cell lung cancer | Q30487266 | ||
Systematic reviewers neglect bias that results from trials stopped early for benefit | Q33293775 | ||
Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses | Q33372680 | ||
No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data | Q33436401 | ||
Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis | Q33470811 | ||
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis | Q33812064 | ||
Bayesian methods in health technology assessment: a review | Q34116699 | ||
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer | Q34398320 | ||
Beta blockade during and after myocardial infarction: an overview of the randomized trials | Q34557544 | ||
Randomized trials in oncology stopped early for benefit | Q34731676 | ||
Is overall survival a realistic primary end point in advanced colorectal cancer studies? A critical assessment based on four clinical trials comparing fluorouracil plus leucovorin with the same treatment combined either with oxaliplatin or with CPT- | Q35700216 | ||
Randomized trials stopped early for benefit: a systematic review | Q36303650 | ||
Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
Analysis of progression-free survival in oncology trials: some common statistical issues | Q36715446 | ||
Recent developments in meta-analysis. | Q36859537 | ||
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions | Q37131226 | ||
Issues in using progression-free survival when evaluating oncology products | Q37231532 | ||
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy | Q37329165 | ||
Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer | Q37344525 | ||
Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison | Q37384150 | ||
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews | Q37433313 | ||
Design, analysis, and presentation of crossover trials | Q37465334 | ||
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses | Q37572176 | ||
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literature | Q37630084 | ||
Checking consistency in mixed treatment comparison meta-analysis | Q37705195 | ||
Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals | Q39834471 | ||
The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care | Q40756644 | ||
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group | Q43607761 | ||
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? | Q43707230 | ||
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group | Q44459245 | ||
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis | Q46987043 | ||
Confidence intervals for the overall effect size in random-effects meta-analysis. | Q47242769 | ||
Exploring the geometry of treatment networks. | Q51691084 | ||
Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. | Q51835764 | ||
Indirect comparisons: the mesh and mess of clinical trials. | Q51929967 | ||
Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. | Q51934574 | ||
Incorporating direct and indirect evidence using bayesian methods: an applied case study in ovarian cancer. | Q51943398 | ||
Borrowing strength from external trials in a meta-analysis. | Q52287071 | ||
Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments | Q57542907 | ||
Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis | Q57995927 | ||
Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials | Q71441157 | ||
Uncertainty of the time of first significance in random effects cumulative meta-analysis | Q71810911 | ||
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer | Q73384968 | ||
Network meta-analysis for indirect treatment comparisons | Q74720205 | ||
Progression-free survival remains debatable endpoint in cancer trials | Q84724961 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meta-analysis | Q815382 |
P304 | page(s) | 193-202 | |
P577 | publication date | 2011-05-27 | |
P1433 | published in | Clinical Epidemiology | Q5133758 |
P1476 | title | Multiple treatment comparison meta-analyses: a step forward into complexity | |
P478 | volume | 3 |
Q34771461 | A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses |
Q38520487 | Assessing key assumptions of network meta-analysis: a review of methods |
Q33165696 | Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis |
Q45848154 | Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis |
Q38927015 | Comparative tolerability of treatments for acute migraine: A network meta-analysis |
Q36549805 | Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis |
Q55360536 | Effectiveness of antimicrobial-coated central venous catheters for preventing catheter-related blood-stream infections with the implementation of bundles: a systematic review and network meta-analysis. |
Q47358265 | Efficacy of targeted therapy for advanced renal cell carcinoma: a systematic review and meta-analysis of randomized controlled trials |
Q35649035 | Emergent approaches to the meta-analysis of multiple heterogeneous complex interventions. |
Q34245961 | Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison |
Q30251972 | GetReal in network meta-analysis: a review of the methodology |
Q35580918 | Intraoperative mechanical ventilation strategies for obese patients: a systematic review and network meta-analysis |
Q38215538 | Low-intensity pulsed ultrasonography versus electrical stimulation for fracture healing: a systematic review and network meta-analysis |
Q36666801 | Lung ventilation strategies for acute respiratory distress syndrome: a systematic review and network meta-analysis |
Q35344092 | Mechanical ventilation modes for respiratory distress syndrome in infants: a systematic review and network meta-analysis |
Q36083592 | Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis |
Q24234278 | Methods to decrease blood loss and transfusion requirements for liver transplantation |
Q38418984 | Network Meta-analysis: Users' Guide for Surgeons: Part I - Credibility |
Q38418988 | Network Meta-analysis: Users' Guide for Surgeons: Part II - Certainty |
Q38199973 | Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective |
Q37745777 | Network meta-analysis: a technique to gather evidence from direct and indirect comparisons |
Q47131728 | Network meta-analysis: application and practice using Stata |
Q37274242 | New methods for determining comparative effectiveness in rheumatoid arthritis |
Q92347153 | Particulate Systems in the Enhancement of the Antiglaucomatous Drug Pharmacodynamics: A Meta-Analysis Study |
Q35727566 | Ranking treatments in frequentist network meta-analysis works without resampling methods. |
Q42386185 | Sample size and power considerations in network meta-analysis |
Q38068922 | Second-line treatments for the management of advanced renal cell carcinoma: systematic review and meta-analysis |
Q42150969 | Stability of additive treatment effects in multiple treatment comparison meta-analysis: a simulation study |
Q38888208 | Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. |
Q48324902 | Systematic reviews for informing clinical practice. |
Q58126326 | The Improvement of Walking Ability Following Stroke |
Q41834701 | The effects of excluding treatments from network meta-analyses: survey |
Q39152263 | The impact of incorporating Bayesian network meta-analysis in cost-effectiveness analysis - a case study of pharmacotherapies for moderate to severe COPD. |
Q33898415 | The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials |
Q31154724 | The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. |
Q97527902 | Transcranial direct current stimulation (tDCS) for improving aphasia after stroke: a systematic review with network meta-analysis of randomized controlled trials |
Q41107792 | Transcranial direct current stimulation (tDCS) for improving capacity in activities and arm function after stroke: a network meta-analysis of randomised controlled trials |
Q62486720 | Trends in comparative efficacy and safety of malaria control interventions for maternal and child health outcomes in Africa: a study protocol for a Bayesian network meta-regression exploring the effect of HIV and malaria endemicity spectrum |
Q40859297 | Unsolved issues of mixed treatment comparison meta-analysis: network size and inconsistency |
Search more.